FLUORINE F-18 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluorine F-18, and what generic alternatives are available?
Fluorine F-18 is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in FLUORINE F-18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluorine F-18
A generic version of FLUORINE F-18 was approved as sodium fluoride f-18 by MCPRF on June 28th, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUORINE F-18?
- What are the global sales for FLUORINE F-18?
- What is Average Wholesale Price for FLUORINE F-18?
Summary for FLUORINE F-18
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| Clinical Trials: | 92 |
| DailyMed Link: | FLUORINE F-18 at DailyMed |
Recent Clinical Trials for FLUORINE F-18
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Andrei Iagaru | Phase 2/Phase 3 |
| AHS Cancer Control Alberta | Phase 2 |
| Nanjing First Hospital, Nanjing Medical University | N/A |
US Patents and Regulatory Information for FLUORINE F-18
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | FLUORINE F-18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 017042-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
